Jacques Planas Morin Institutions of which they are part Biomedical Research in Urology Vall Hebron Institut de Recerca Email Jacques Planas Morin Email Institutions of which they are part Biomedical Research in Urology Vall Hebron Institut de Recerca
Research lines Hormone therapy and castrate resistant prostate cancer (Clinical research) One main objective is the optimization of androgen suppression and to know its safety profile, specifically in the areas of bone mass loss, the metabolic disturbances and cognitive performance. How to perform early diagnosis of CRPC, and how to follow up the new treatments are also objectives of this line. IP: Jacques Planas Morin Projects Incorporación de métodos de imagen y perfiles moleculares para mejorar el cribado de cáncer de próstata en portadores de mutaciones en genes de las vías de reparación de ADN. IP: Olga Méndez Fernández Collaborators: Berta Miró Cau, Marc Simo Perdigo, David Ruiz Casajuana, Jacques Planas Morin, Richard Mast Funding agency: Instituto de Salud Carlos III Funding: 127500 Reference: PI23/01310 Duration: 01/01/2024 - 31/12/2026 Rercerca biomèdica en urologia IP: Joan Morote Robles Collaborators: Fernando Lozano Palacio, Inés de Torres Ramirez, Rercerca biomèdica en urologia , Enric Trilla Herrera, Olga Méndez Fernández, Ana Celma Domènech, Mercè Cuadras Solé, Carlos Serrano Burgos, Albert Carrión Puig , Enric Miret Alomar, Maria Eugenia Semidey Raven, Carles Xavier Raventós Busquets, David Ruiz Casajuana, Jacques Planas Morin, Richard Mast, Anna Santamaria Margalef Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 00858 Duration: 01/01/2022 - 30/06/2025 Nuevas estrategias para la mejora del diagnóstico y el manejo terapéutico de los portadores de mutaciones en BRCA2 IP: Anna Santamaria Margalef Collaborators: Mercè Cuadras Solé, Jacques Planas Morin Funding agency: Instituto de Salud Carlos III Funding: 159720 Reference: PI21/00977 Duration: 01/01/2022 - 31/12/2024 Radiogenomics for the prediction of prostate cancer aggressiveness through artificial intelligence. IP: Joan Morote Robles Collaborators: Inés de Torres Ramirez, Ana Celma Domènech, Jacques Planas Morin, Richard Mast, Lucas Regis Plácido Funding agency: Instituto de Salud Carlos III Funding: 159720 Reference: PI20/01666 Duration: 01/01/2021 - 30/06/2025 Pagination Current page 1 Page 2 Page 3 Next page › Last page »
